Literature DB >> 22399427

Mitochondria in neurodegeneration.

E Lezi1, Russell H Swerdlow.   

Abstract

Many neurodegenerative diseases demonstrate abnormal mitochondrial morphology and biochemical dysfunction. Alterations are often systemic rather than brain-limited. Mitochondrial dysfunction may arise as a consequence of abnormal mitochondrial DNA, mutated nuclear proteins that interact directly or indirectly with mitochondria, or through unknown causes. In most cases it is unclear where mitochondria sit in relation to the overall disease cascades that ultimately causes neuronal dysfunction and death, and there is still controversy regarding the question of whether mitochondrial dysfunction is a necessary step in neurodegeneration. In this chapter we highlight and catalogue mitochondrial perturbations in some of the major neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). We consider data that suggest mitochondria may be critically involved in neurodegenerative disease neurodegeneration cascades.

Entities:  

Mesh:

Year:  2012        PMID: 22399427      PMCID: PMC3618469          DOI: 10.1007/978-94-007-2869-1_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  156 in total

Review 1.  The burden of dementia. A medical and research perspective.

Authors:  P Antuono; J Beyer
Journal:  Theor Med Bioeth       Date:  1999-01

2.  Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease.

Authors:  S M de la Monte; T Luong; T R Neely; D Robinson; J R Wands
Journal:  Lab Invest       Date:  2000-08       Impact factor: 5.662

3.  Deleted 4977-bp mitochondrial DNA mutation is associated with sporadic amyotrophic lateral sclerosis: a hospital-based case-control study.

Authors:  Long-Sun Ro; Shiao-Lin Lai; Chiung-Mei Chen; Sien-Tsong Chen
Journal:  Muscle Nerve       Date:  2003-12       Impact factor: 3.217

4.  Maternal inheritance in Parkinson's disease.

Authors:  G F Wooten; L J Currie; J P Bennett; M B Harrison; J M Trugman; W D Parker
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

5.  Mitochondrial function in Parkinson's disease.

Authors:  L A Bindoff; M Birch-Machin; N E Cartlidge; W D Parker; D M Turnbull
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

6.  Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.

Authors:  Patrick Weydt; Victor V Pineda; Anne E Torrence; Randell T Libby; Terrence F Satterfield; Eduardo R Lazarowski; Merle L Gilbert; Gregory J Morton; Theodor K Bammler; Andrew D Strand; Libin Cui; Richard P Beyer; Courtney N Easley; Annette C Smith; Dimitri Krainc; Serge Luquet; Ian R Sweet; Michael W Schwartz; Albert R La Spada
Journal:  Cell Metab       Date:  2006-10-19       Impact factor: 27.287

7.  beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria.

Authors:  L Canevari; J B Clark; T E Bates
Journal:  FEBS Lett       Date:  1999-08-20       Impact factor: 4.124

8.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

Authors:  Joseph T Rodgers; Carlos Lerin; Wilhelm Haas; Steven P Gygi; Bruce M Spiegelman; Pere Puigserver
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

9.  Cytochrome c oxidase is decreased in Alzheimer's disease platelets.

Authors:  Sandra Morais Cardoso; M Teresa Proença; Sancha Santos; Isabel Santana; Catarina R Oliveira
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

10.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

Authors:  Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

View more
  67 in total

1.  Carnosic Acid Suppresses the H2O2-Induced Mitochondria-Related Bioenergetics Disturbances and Redox Impairment in SH-SY5Y Cells: Role for Nrf2.

Authors:  Marcos Roberto de Oliveira; Gustavo da Costa Ferreira; Alessandra Peres; Simone Morelo Dal Bosco
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

Review 2.  The Autophagy Lysosomal Pathway and Neurodegeneration.

Authors:  Steven Finkbeiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-03-02       Impact factor: 10.005

3.  Suppression of oxidative phosphorylation in mouse embryonic fibroblast cells deficient in apurinic/apyrimidinic endonuclease.

Authors:  Rangaswamy Suganya; Anirban Chakraborty; Sumitra Miriyala; Tapas K Hazra; Tadahide Izumi
Journal:  DNA Repair (Amst)       Date:  2015-01-16

4.  Sustained O-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism.

Authors:  Ee Phie Tan; Steven R McGreal; Stefan Graw; Robert Tessman; Scott J Koppel; Pramod Dhakal; Zhen Zhang; Miranda Machacek; Natasha E Zachara; Devin C Koestler; Kenneth R Peterson; John P Thyfault; Russell H Swerdlow; Partha Krishnamurthy; Luciano DiTacchio; Udayan Apte; Chad Slawson
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

5.  Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.

Authors:  Jeffrey M Statland; Dan Moore; Yunxia Wang; Maureen Walsh; Tahseen Mozaffar; Lauren Elman; Sharon P Nations; Hiroshi Mitsumoto; J Americo Fernandes; David Saperstein; Ghazala Hayat; Laura Herbelin; Chafic Karam; Jonathan Katz; Heather M Wilkins; Abdulbaki Agbas; Russell H Swerdlow; Regina M Santella; Mazen M Dimachkie; Richard J Barohn
Journal:  Muscle Nerve       Date:  2018-11-26       Impact factor: 3.217

6.  Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injury.

Authors:  Sara M Garrett; Ryan M Whitaker; Craig C Beeson; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2014-05-21       Impact factor: 4.030

7.  Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging.

Authors:  Suzanne Goh; Zhengchao Dong; Yudong Zhang; Salvatore DiMauro; Bradley S Peterson
Journal:  JAMA Psychiatry       Date:  2014-06       Impact factor: 21.596

Review 8.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Effect of a trans fatty acid-enriched diet on mitochondrial, inflammatory, and oxidative stress parameters in the cortex and hippocampus of Wistar rats.

Authors:  Rafael Longhi; Roberto Farina Almeida; Leticia Ferreira Pettenuzzo; Débora Guerini Souza; Letiane Machado; André Quincozes-Santos; Diogo Onofre Souza
Journal:  Eur J Nutr       Date:  2017-05-31       Impact factor: 5.614

Review 10.  Does PGC1α/FNDC5/BDNF Elicit the Beneficial Effects of Exercise on Neurodegenerative Disorders?

Authors:  Mohammad Jodeiri Farshbaf; Kamran Ghaedi; Timothy L Megraw; Jennifer Curtiss; Mahsa Shirani Faradonbeh; Pooneh Vaziri; Mohammad Hossein Nasr-Esfahani
Journal:  Neuromolecular Med       Date:  2015-11-26       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.